News about Drug Discovery & Development

GSK introduces Shingrix vaccine in India

Shingrix is the world’s first non-live, recombinant subunit vaccine to be given intramuscularly in two doses

Drug Discovery & Development | 25/04/2023 | By Sudeep Soparkar |  2568

Sai Life Sciences unveils opens research facility for Schrodinger in Hyderabad

In January 2023, Sai Life Sciences entered into a five-year strategic agreement with Schrodinger

Drug Discovery & Development | 21/04/2023 | By Sudeep Soparkar |  929

Cipla in pact with Novartis Pharma for diabetes drug Galvus

During the interim Cipla will continue to market and distribute Galvus-branded products

Drug Discovery & Development | 17/04/2023 | By Sudeep Soparkar |  1057

NATCO launches additional strengths for generic version of Revlimid in US

The generic version of Revlimid (lenalidomide capsules) are of strengths in 2.5 mg, and 20 mg

Drug Discovery & Development | 11/03/2023 | By Sudeep Soparkar |  1065

SK bioscience to Establish a Vaccine-Biopharma Hub

The R&PD center will be a 30,413.8 sq mt site in Songdo, Republic of Korea

Drug Discovery & Development | 13/02/2023 | By Sudeep Soparkar |  629

Mettler-Toledo Product Inspection to display wide range of pharma products at Interpack trade fair in May 2023

Under the banner theme of 'Boost Your Productivity' the Mettler-Toledo booth, A60 in Hall 11 at the Messe Düsseldorf, Germany, will comprise several different themed 'islands'

Drug Discovery & Development | 07/02/2023 | By Sudeep Soparkar |  610

Seqens opens flagship R&D centre in Greater Boston

The new facility will provide advanced capabilities for the discovery and development of new drugs and therapeutics
<br />

Drug Discovery & Development | 02/02/2023 | By Sudeep Soparkar |  1107

Aptar Pharma launches first metal-free nasal spray pump

Specifically designed for recyclability, APF Futurity is Aptar Pharma’s first highly recyclable nasal spray pump

Drug Discovery & Development | 31/01/2023 | By Sudeep Soparkar |  1020

Sun Pharma Launches SEZABY in US to treat neonatal seizures

This is the first and only FDA Approved product in US to treat neonatal seizures

Drug Discovery & Development | 27/01/2023 | By Sudeep Soparkar |  1093

ENTOD Pharma's state-of-the-art R&D facility opens in Navi Mumbai

The brand new additional R&D facility in Navi Mumbai has been designed with state-of-the-art equipment and the latest analytical & formulation research tools

Drug Discovery & Development | 27/01/2023 | By Sudeep Soparkar |  879